(Q41757024)

8 October 2017

1 reference

title

Capromab pendetide. A review of its use as an imaging agent in prostate cancer (English)

1 reference

8 October 2017

H M Lamb

1

1 reference

8 October 2017

D Faulds

series ordinal

2

1 reference

8 October 2017

publication date

1 April 1998

1 reference

8 October 2017

1 reference

8 October 2017

volume

12

1 reference

8 October 2017

issue

4

1 reference

8 October 2017

page(s)

293-304

1 reference

https://scigraph.springernature.com/pub.10.2165/00002512-199812040-00004

8 October 2017

exact match

0 references

cites work

Monoclonal antibodies to a new antigenic marker in epithelial prostatic cells and serum of prostatic cancer patients

1 reference

12 December 2020

Development of monoclonal antibody imaging of metastatic prostatic carcinoma

1 reference

12 December 2020

Radiation absorbed dose from indium-111-CYT-356

1 reference

12 December 2020

Radioimmunoscintigraphy of pelvic lymph nodes with 111indium-labeled monoclonal antibody CYT-356

1 reference

12 December 2020

Current status of monoclonal antibodies for imaging and therapy of prostate cancer.

1 reference

12 December 2020

Radioimmunodetection of prostatic cancer. In vivo use of radioactive antibodies against prostatic acid phosphatase for diagnosis and detection of prostatic cancer by nuclear imaging

1 reference

12 December 2020

Long-Term (15 Years) Results After Radical Prostatectomy For Clinically Localized (Stage T2c Or Lower) Prostate Cancer

1 reference

12 December 2020

Technical considerations for acquiring and processing indium-111 capromab pendetide images

1 reference

12 December 2020

Biochemical characterization and mapping of the 7E11-C5.3 epitope of the prostate-specific membrane antigen

1 reference

12 December 2020

Expression of the prostate-specific membrane antigen

1 reference

12 December 2020

Monoclonal antibodies to the extracellular domain of prostate-specific membrane antigen also react with tumor vascular endothelium

1 reference

12 December 2020

Upregulation of prostate-specific membrane antigen after androgen-deprivation therapy

1 reference

12 December 2020

Prostate-specific membrane antigen expression in normal and malignant human tissues

1 reference

12 December 2020

Are pelvic computed tomography, bone scan and pelvic lymphadenectomy necessary in the staging of prostatic cancer?

1 reference

12 December 2020

Expression of prostate-specific membrane antigen in normal, benign, and malignant prostate tissues

1 reference

12 December 2020

Prostate-specific membrane antigen: a novel folate hydrolase in human prostatic carcinoma cells

1 reference

12 December 2020

Measurement of prostate-specific membrane antigen in the serum with a new antibody

1 reference

12 December 2020

Radioimmunoscintigraphy with 111indium labeled CYT-356 for the detection of occult prostate cancer recurrence

1 reference

12 December 2020

Location of prostate-specific membrane antigen in the LNCaP prostate carcinoma cell line

1 reference

12 December 2020

Radioimmunoscintigraphy with In-111-labeled capromab pendetide predicts prostate cancer response to salvage radiotherapy after failed radical prostatectomy

1 reference

12 December 2020

Clinical experience with intra lymphatic administration of 111In-labelled monoclonal antibody PAY 276 for the detection of pelvic nodal metastases in prostatic carcinoma

1 reference

12 December 2020

Immunoscintigraphy of prostatic cancer: preliminary results with 111In-labeled monoclonal antibody 7E11-C5.3 (CYT-356)

1 reference

12 December 2020

Prostate cancer diagnosis and management

1 reference

12 December 2020

Trials and tribulations: oncological antibody imaging comes to the fore

1 reference

12 December 2020

Monoclonal antibodies and radioimmunoconjugates in the diagnosis and treatment of prostate cancer

1 reference

12 December 2020

Monoclonal antibody imaging of occult prostate cancer in patients with elevated prostate-specific antigen. Positron emission tomography and biopsy correlation

1 reference

12 December 2020

Radical prostatectomy for adenocarcinoma of the prostate: the influence of preoperative and pathologic findings on biochemical disease-free outcome

1 reference

12 December 2020

Monoclonal antibody 7E11.C5 staining of viable LNCaP cells

1 reference

12 December 2020

Radioimmunological imaging of metastatic prostatic cancer with 111indium-labeled monoclonal antibody PAY 276

1 reference

12 December 2020

Comparison of prostate specific membrane antigen, and prostate specific antigen levels in prostatic cancer patients.

1 reference

12 December 2020

Molecular cloning of a complementary DNA encoding a prostate-specific membrane antigen

1 reference

12 December 2020

Detection and characterization of the prostate-specific membrane antigen (PSMA) in tissue extracts and body fluids

1 reference

12 December 2020

Serum PSA after anatomic radical prostatectomy. The Johns Hopkins experience after 10 years

1 reference

12 December 2020

Alternatively spliced variants of prostate-specific membrane antigen RNA: ratio of expression as a potential measurement of progression

1 reference

12 December 2020

Prostate-specific membrane antigen is a hydrolase with substrate and pharmacologic characteristics of a neuropeptidase

1 reference

12 December 2020

Report of the consensus workshop on screening and global strategy for prostate cancer

1 reference

12 December 2020

Prostate specific antigen levels after radical prostatectomy in patients with organ confined and locally extensive prostate cancer

1 reference

12 December 2020

Comparison of prostate specific antigen, prostate specific membrane antigen, and LNCaP-based enzyme-linked immunosorbent assays in prostatic cancer patients and patients with benign prostatic enlargement.

1 reference

12 December 2020

Characterization and glutamyl preferring carboxypeptidase function of prostate specific membrane antigen: a novel folate hydrolase.

1 reference

12 December 2020

Immunohistochemical and pharmacokinetic characterization of the site-specific immunoconjugate CYT-356 derived from antiprostate monoclonal antibody 7E11-C5

1 reference

12 December 2020

Monoclonal antibody imaging of recurrent and metastatic prostate cancer

1 reference

12 December 2020

Radioimmunoscintigraphy of prostate cancer

1 reference

12 December 2020

Imaging prostate cancer with technetium-99m-7E11-C5.3 (CYT-351)

1 reference

12 December 2020

10.2165/00002512-199812040-00004

Identifiers

DOI

1 reference

Dimensions Publication ID

8 October 2017

1033081102

0 references

1 reference